IN HB1125 | 2021 | Regular Session
Status
Spectrum: Slight Partisan Bill (Republican 4-2)
Status: Engrossed on February 18 2021 - 50% progression
Action: 2021-02-24 - First reading: referred to Committee on Judiciary
Pending: Senate Judiciary Committee
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on February 18 2021 - 50% progression
Action: 2021-02-24 - First reading: referred to Committee on Judiciary
Pending: Senate Judiciary Committee
Text: Latest bill text (Engrossed) [PDF]
Summary
Deceptive lead generation. Makes false, misleading, or deceptive advertisements for claims related to medical devices and legend drugs and certain other actions a deceptive act.
Title
Deceptive lead generation.
Sponsors
Rep. Matthew Lehman [R] | Rep. Gregory Steuerwald [R] | Rep. Julie Olthoff [R] | Rep. Ryan Hatfield [D] |
Sen. Elizabeth Brown [R] | Sen. Karen Tallian [D] |
Roll Calls
2021-02-17 - House - House - Third reading (Y: 97 N: 1 NV: 1 Abs: 1) [PASS]
2021-02-09 - House - House - Committee Vote (Y: 11 N: 0 NV: 0 Abs: 2) [PASS]
2021-02-09 - House - House - Committee Vote (Y: 11 N: 0 NV: 0 Abs: 2) [PASS]
History
Date | Chamber | Action |
---|---|---|
2021-02-24 | Senate | First reading: referred to Committee on Judiciary |
2021-02-18 | House | Referred to the Senate |
2021-02-17 | House | Senate sponsors: Senators Brown L and Tallian |
2021-02-17 | House | Third reading: passed; Roll Call 179: yeas 97, nays 1 |
2021-02-16 | House | Representatives Olthoff and Hatfield added as coauthors |
2021-02-16 | House | Representatives Schaibley and Hatfield removed as coauthors |
2021-02-16 | House | Amendment #1 (Steuerwald) prevailed; voice vote |
2021-02-16 | House | Second reading: amended, ordered engrossed |
2021-02-15 | House | Representatives Steuerwald, Schaibley, Hatfield added as coauthors |
2021-02-11 | House | Committee report: amend do pass, adopted |
2021-01-07 | House | First reading: referred to Committee on Judiciary |
2021-01-07 | House | Authored by Representative Lehman |